| 000 | 01641 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516172044.0 | ||
| 264 | 0 | _c20140130 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-013-2296-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParise, Robert A | |
| 245 | 0 | 0 |
_aEffects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cDec 2013 |
||
| 300 |
_a1195-204 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 |
_aAldehyde Dehydrogenase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBenzaldehydes _xpharmacokinetics |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
| 650 | 0 | 4 |
_aDisulfiram _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aMice |
| 700 | 1 | _aBeumer, Jan H | |
| 700 | 1 | _aClausen, Dana M | |
| 700 | 1 | _aRigatti, Lora H | |
| 700 | 1 | _aZiegler, Judy A | |
| 700 | 1 | _aGasparetto, Maura | |
| 700 | 1 | _aSmith, Clayton A | |
| 700 | 1 | _aEiseman, Julie L | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 72 _gno. 6 _gp. 1195-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-013-2296-5 _zAvailable from publisher's website |
| 999 |
_c23113070 _d23113070 |
||